Tao Levy - Nov 13, 2024 Form 4 Insider Report for MASIMO CORP (MASI)

Role: EVP, Bus Dev
Signature: /s/ Micah W. Young, Attorney-In-Fact
Stock symbol: MASI
Transactions as of: Nov 13, 2024
Transactions value $: -$2,327,869
Form type: 4
Date filed: 11/15/2024, 06:05 PM
Previous filing: Mar 1, 2024

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	MASI	Common Stock	Options Exercise	$0	+30K	+267.67%	$0.00	41.2K	Nov 13, 2024	Direct
transaction	MASI	Common Stock	Tax liability	-$2.33M	-14.4K	-34.94%	$161.68	26.8K	Nov 13, 2024	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	MASI	Restricted Stock Units	Options Exercise	$0	-30K	-100%	$0.00	0	Nov 13, 2024	Common Stock	30K		Direct	F2, F3, F4

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	These shares were withheld by the Issuer in order to satisfy certain tax withholding obligations in connection with the issuance of shares upon the vesting of certain performance restricted stock units.
F2	Each restricted stock unit (RSU) represents the contingent right to receive one share of common stock of the Issuer upon vesting of the RSU.
F3	These RSUs were granted on March 1, 2024.
F4	On November 13, 2024, in connection with its strategic shift to refocus on its core healthcare business, Masimo Corporation ("the Company") terminated the employment of Tao Levy, the Company's Executive Vice President, Business Development. 100% of the unvested RSUs vested in full upon Mr. Levy's covered termination, as defined by the Masimo Corporation 2017 Equity Incentive Plan Restricted Stock Unit Award Agreement.